Do antidepressant advertisements educate consumers and promote communication between patients with depression and their physicians?

Patient Education and Counseling

Volumn 81, Issue 2, 2010, Pages 245-250

  Bell, Robert A ^a,b   Taylor, Laramie D ^a   Kravitz, Richard L ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Advertisements; Advertising; Antidepressants; Chemical imbalance; Depression; Direct to consumer; Drugs; Marketing; Patient requests; Prescription; Promotion

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; DOXEPIN; DULOXETINE; ESCITALOPRAM; NORTRIPTYLINE; PAROXETINE; SERTRALINE; TRAZODONE; VENLAFAXINE;

ADULT; ARTICLE; AWARENESS; CHRONICITY; CONSUMER ATTITUDE; CONSUMER HEALTH INFORMATION; DEPRESSION; DOCTOR PATIENT RELATION; DRUG EFFICACY; DRUG MARKETING; DRUG SAFETY; FEMALE; GENDER BIAS; HEALTH BELIEF; HUMAN; MAJOR CLINICAL STUDY; MALE; ONLINE SYSTEM; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOTHERAPY; QUESTIONNAIRE; SUPPORT GROUP;

ADOLESCENT; ADULT; ADVERTISING AS TOPIC; AGED; ANTIDEPRESSIVE AGENTS; COMMUNICATION; CONSUMER PARTICIPATION; DEPRESSION; DRUG INDUSTRY; FEMALE; HUMANS; INTERNET; MALE; MIDDLE AGED; PATIENT PARTICIPATION; PHYSICIAN-PATIENT RELATIONS; QUESTIONNAIRES; SELF-HELP GROUPS; SOCIOECONOMIC FACTORS; UNITED STATES; YOUNG ADULT;

EID: 77957286739     PISSN: 07383991     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pec.2010.01.014     Document Type: Article

References (46)

1. The Nielsen Company. U.S. ad spending fell 2.6% in 2008, Nielsen reports. News Release, March 13, 2009. [available online at ]. http://blog.nielsen.com/nielsenwire/wp-content/uploads/2009/03/nielsen2008adspend-release.pdf.
2. Kelly P. DTC advertising's benefits far outweigh imperfections. Health Aff 2004, w4:246-248.
3. Bell R.A., Wilkes M.S., Kravitz R.L. Advertising-induced prescription drug requests: patients' anticipated reactions to a physician who refuses. J Fam Pract 1999, 48:446-452.
4. Robinson A.R., Hohmann K.B., Rifkin J.I., Gilroy C.M., Pickard J.A., Anderson R.J. Direct-to-consumer pharmaceutical advertising: physician and public opinion and potential effects on the physician-patient relationship. Arch Intern Med 2004, 164:427-432.
5. National Conference of State Legislatures. Marketing and direct-to-consumer advertising (DTCA) of pharmaceuticals. Online report, available at [accessed September 21, 2009]. http://www.ncsl.org/default.aspx?tabid=14461.
6. Rosenthal M.B., Berndt E.R., Donohue J.M., Frank R.G., Epstein A.M. Promotion of prescription drugs to consumers. N Engl J Med 2002, 346:498-505.
7. Donohue J.M., Cevasco M., Rosenthal M.B. A decade of direct-to-consumer advertising of prescription drugs. N Engl J Med 2007, 357:673-681.
8. Eysenbach G., Powell J., Englesakis M., Rizo C., Stern A. Health related virtual communities and electronic support groups: systematic review of the effects of online peer to peer interactions. Brit Med J 2004, 328(7449):1166.
9. Fox S., Jones S. The social life of health information 2009, Pew Internet & American Life Project, Washington, DC.
10. Beaudoin C.E., Chen-Chao T. Benefiting from social capital in online support groups: an empirical study of cancer patients. Cyberpsychol Behav 2007, 10:587-590.
11. Beltramini R.F. Consumer believability of information in direct-to-consumer (DTC) advertising of prescription drugs. J Business Ethics 2006, 63:333-343.
12. Wilkes M.S., Bell R.A., Kravitz R.L. Direct-to-consumer prescription drug advertising: trends, impact, and implications. Health Aff 2000, 19(2):110-128.
13. Murray E., Lo B., Pollack L., Donelan K., Lee K. Direct-to-consumer advertising: public perceptions of its effects on health behavior, health care, and the doctor-patient relationship. J Am Board Fam Pract 2004, 17:6-18.
14. Singh T., Smith D. Direct-to-consumer prescription drug advertising: a study of consumer attitudes and behavioral intentions. J Consumer Market 2005, 22:369-378.
15. Bell R.A., Kravitz R.L., Wilkes M.S. Direct-to-consumer prescription drug advertising and the public. J Gen Intern Med 1999, 14:651-657.
16. Bell R.A., Wilkes M.S., Kravitz R.L. The educational value of consumer-targeted prescription drug print advertising. J Fam Pract 2000, 49:1092-1098.
17. Kravitz R.L., Bell R.A. Direct-to-consumer advertising of prescription drugs: balancing benefits and risks, and a way forward. Clin Pharmacol Ther 2007, 82:360-362.
18. Macias W., Pashupati K., Lewis L.S. A wonderful life of diarrhea and dry mouth? Policy issues of direct-to-consumer drug advertising on television. Health Commun 2007, 22:241-252.
19. Lacasse J.R. Consumer advertising of psychiatric medications biases the public against nonpharmacological treatment. Ethical Hum Psychol Psychiatry 2005, 7:175-179.
20. Atkin J.L., Beltramini R.F. Exploring the perceived believability of DTC advertising in the US. J Market Commun 2007, 13:169-180.
21. Polen H.H., Khanfar N.M., Clauson K.A. Impact of direct-to-consumer advertising (DTCA) on patient health-related behaviors and issues. Health Market Q 2009, 26:42-55.
22. Morris L.A., Brinberg D., Klimberg R., Rivera C., Millstein L.G. The attitudes of consumers toward direct advertising of prescription drugs. Public Health Reports 1986, 101:82-89.
23. Perri M., Nelson A.A. An exploratory analysis of consumer recognition of direct-to-consumer advertising of prescription medications. J Health Care Market 1987, 7:35-41.
24. Williams J.R., Hensell P.J. Direct-to-consumer advertising of prescription drugs. J Health Care Market 1995, 15:35-41.
25. Deshpande A., Menon A., Perri M., Zinkhan G. Direct-to-consumer advertising and its utility in health care decision making: a consumer perspective. J Health Commun 2004, 9:499-513.
26. Peyrot M., Alperstein N.M., Van Doren D., Poli L. Direct to consumer ads can influence behavior. Market Health Serv 1998, 18(2):26-32.
27. Sumpradit N., Fors S.W., McCormick L. Consumers' attitudes and behavior toward prescription drug advertising. Am J Health Behav 2002, 26:68-75.
28. Herzenstein M., Misra S., Posavac S. How consumers' attitudes toward direct-to-consumer advertising of prescription drugs influence ad effectiveness, and consumer and physician behavior. Market Lett 2005, 15:201-212.
29. An S. Attitude toward direct-to-consumer advertising and drug inquiry intention: the moderating role of perceived knowledge. J Health Commun 2007, 12:567-580.
30. Martinez L.S., Lewis N. The role of direct-to-consumer advertising in shaping public opinion surrounding prescription drug use to treat depression or anxiety in youth. J Health Commun 2009, 14:246-261.
31. Huang A.J. The rise of direct-to-consumer advertising of prescription drugs in the United States. J Amer Med Assoc 2000, 284:2240.
32. Kravitz R.L., Epstein R.M., Feldman M.D., Franz C.E., Azari R., Wilkes M.S., et al. Influence of patients' requests for direct-to-consumer advertised antidepressants: a randomized controlled trial. J Amer Med Assoc 2005, 293:1995-2002.
33. Block A.E. Cost and benefits of direct-to-consumer advertising: the case of depression. Pharmacoeconomics 2007, 25:511-521.
34. Donohue J.M., Berndt E.R., Rosenthal M., Epstein A.M., Frank R.G. Effects of pharmaceutical promotion on adherence to the treatment guidelines for depression. Med Care 2004, 42:1176-1185.
35. France C.M., Lysaker P.H., Robinson R.P. The " chemical imbalance" explanation for depression: origins, lay endorsements, and clinical implications. Prof Psychol: Res Pract 2007, 38:41-420.
36. Lacasse L.R., Leo J. Serotonin and depression: a disconnect between the advertisements and the scientific literature. PLoS Med 2005, 2(12):e392.
37. Chananie R.A. Psychopharmaceutical advertising strategies: empowerment in a pill?. Sociol Spectr 2005, 25:487-518.
38. Gilbody S., Wilson P., Watt I. Direct-to-consumer advertising of psychotropics: an emerging and evolving form of pharmaceutical company influence. Br J Psychiatry 2004, 185:1-2.
39. Grow J.M., Park J.S., Han X. " Your life is waiting!": Symbolic meanings in direct-to-consumer antidepressant advertising. J Commun Inquiry 2006, 30:163-188.
40. Park J.S., Grow J.M. The social realty of depression: DTC advertising of antidepressants and perceptions of the prevalence and lifetime risk of depression. J Business Ethics 2008, 79:379-393.
41. An S. Antidepressant direct-to-consumer advertising and social perception of the prevalence of depression: application of the availability heuristic. Health Commun 2008, 23:499-505.
42. Kroenke K., Spitzer R.L., Williams J.B.W. The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care 2003, 41:1284-1292.
43. Cronbach L.J. Coefficient alpha and the internal structure of tests. Psychometrika 1951, 16:297-334.
44. Feldman M.D., Franks P., Epstein R.M., Franz C.E., Kravitz R.L. Do patient requests for antidepressants enhance or hinder physicians' evaluation of depression? A randomized controlled trial. Med Care 2006, 44:1107-1113.
45. Lorence D., Churchill R. A study of the web as DTC drug marketing agent. J Med Syst 2007, 31:551-556.
46. Lee A.L. Changing effects of direct-to-consumer broadcast drug advertising information sources on prescription drug requests. Health Commun 2009, 24:361-376.